177 related articles for article (PubMed ID: 32787692)
1. Prognostic Factors in Patients With Osteosarcoma With the Surveillance, Epidemiology, and End Results Database.
Fu P; Shi Y; Chen G; Fan Y; Gu Y; Gao Z
Technol Cancer Res Treat; 2020; 19():1533033820947701. PubMed ID: 32787692
[TBL] [Abstract][Full Text] [Related]
2. Construction and Validation of Nomograms for Predicting the Prognosis of Juvenile Osteosarcoma: A Real-World Analysis in the SEER Database.
Jiang Y; Wang T; Wei Z
Technol Cancer Res Treat; 2020; 19():1533033820947718. PubMed ID: 33054584
[TBL] [Abstract][Full Text] [Related]
3. Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
Ilcisin LA; Ma C; Janeway KA; DuBois SG; Shulman DS
Pediatr Blood Cancer; 2021 Mar; 68(3):e28834. PubMed ID: 33258278
[TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
5. Establishment and validation of a competitive risk model for predicting cancer-specific survival in patients with osteosarcoma: a population-based study.
Wu X; Wang J; He D
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15383-15394. PubMed ID: 37639006
[TBL] [Abstract][Full Text] [Related]
6. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.
Song K; Song J; Lin K; Chen F; Ma X; Jiang J; Li F
Int Orthop; 2019 Aug; 43(8):1983-1991. PubMed ID: 31127366
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of sarcomas occurring in bone and joint: A SEER based study.
Zhou H; He S; Zhang D; Wang J; Yang X; Jiao J; Xu W; Yang J; Xiao J
Medicine (Baltimore); 2023 Oct; 102(43):e34231. PubMed ID: 37904412
[TBL] [Abstract][Full Text] [Related]
9. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
10. Real-world impact of chemotherapy on overall survival in craniomaxillofacial osteosarcoma.
Li YH; Zheng L; Chen GC; Zhang YM; Xu YZ; Huang YF
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101807. PubMed ID: 38431082
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors, disparity, and equity variables impacting prognosis in bone sarcomas of the hand: SEER database review.
Jawad MU; Bayne CO; Farhan S; Haffner MR; Carr-Ascher J; Alvarez E; Thorpe SW; Randall RL
J Surg Oncol; 2021 Dec; 124(8):1515-1522. PubMed ID: 34432316
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and prognostic factors of adult patients with osteosarcoma from the SEER database.
Deng G; Chen P
Medicine (Baltimore); 2023 Sep; 102(37):e33653. PubMed ID: 37713904
[TBL] [Abstract][Full Text] [Related]
13. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
14. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
Wang B; Chen LJ; Wang XY
Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
[TBL] [Abstract][Full Text] [Related]
15. The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma.
Cao Z; Zhang Y; Xu Q; Yu X; Liu X; Dai M
Technol Cancer Res Treat; 2021; 20():15330338211066195. PubMed ID: 34918558
[No Abstract] [Full Text] [Related]
16. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and nomogram of pediatric and young adulthood osteosarcoma patients with synchronous lung metastasis: A SEER analysis.
Liu T; Cui L; He Z; Chen Z; Tao H; Yang J
PLoS One; 2023; 18(7):e0288492. PubMed ID: 37437020
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Determinants Analysis and Nomogram for Bone Malignant Vascular Tumors: A Surveillance, Epidemiology and End Results (SEER) Analysis.
Hu S; Wang X
Med Sci Monit; 2020 Jul; 26():e923305. PubMed ID: 32690858
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
